OTCMKTS:KNWN Know Labs (KNWN) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest About Know Labs Stock (OTCMKTS:KNWN) 30 days 90 days 365 days Advanced Chart Remove Ads Get Know Labs alerts:Sign Up Key Stats Today's Range N/A50-Day Range$1.45▼$8.0552-Week Range N/AVolume2,146 shsAverage Volume1.03 million shsMarket Capitalization$9.00 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewKnow Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood glucose levels. The company was formerly known as Visualant, Incorporated and changed its name to Know Labs, Inc. in May 2018. Know Labs, Inc. was founded in 1998 and is headquartered in Seattle, Washington.Read More… Remove Ads Know Labs Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks11th Percentile Overall ScoreKNWN MarketRank™: Know Labs scored higher than 11% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Know Labs. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Know Labs is -15.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Know Labs is -15.75, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted1.43% of the float of Know Labs has been sold short.Short Interest Ratio / Days to CoverKnow Labs has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Know Labs has recently decreased by 62.09%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldKnow Labs does not currently pay a dividend.Dividend GrowthKnow Labs does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted1.43% of the float of Know Labs has been sold short.Short Interest Ratio / Days to CoverKnow Labs has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Know Labs has recently decreased by 62.09%, indicating that investor sentiment is improving significantly. News and Social Media1.1 / 5News SentimentN/A Search Interest1 people have searched for KNWN on MarketBeat in the last 30 days. MarketBeat Follows3 people have added Know Labs to their MarketBeat watchlist in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Know Labs insiders have not sold or bought any company stock.Percentage Held by Insiders15.40% of the stock of Know Labs is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 23.96% of the stock of Know Labs is held by institutions.Read more about Know Labs' insider trading history. Receive KNWN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Know Labs and its competitors with MarketBeat's FREE daily newsletter. Email Address KNWN Stock News HeadlinesKnow Labs Announces Approval to Begin Trading on the OTCQB MarketFebruary 27, 2025 | businesswire.comKnow Labs Provides Update on its Intellectual Property PortfolioFebruary 26, 2025 | tmcnet.comElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest breakthrough in artificial intelligence… but in human technology. It’s so valuable that some are referring to it as the “new gold”.March 12, 2025 | True Market Insiders (Ad)Know Labs Provides Update on its Intellectual Property PortfolioFebruary 26, 2025 | businesswire.comKnow Labs Technology Licensing (KTL) Announces Formalized Client EngagementFebruary 6, 2025 | tmcnet.comKnow Labs Technology Licensing (KTL) Announces Formalized Client EngagementFebruary 6, 2025 | businesswire.comKnow Labs Files Appeal to NYSE Commencement of Proceedings to DelistFebruary 5, 2025 | finance.yahoo.comKNOW LABS INC (KNWN)February 4, 2025 | finance.yahoo.comSee More Headlines KNWN Stock Analysis - Frequently Asked Questions How were Know Labs' earnings last quarter? Know Labs, Inc. (OTCMKTS:KNWN) announced its quarterly earnings data on Friday, February, 14th. The company reported ($1.60) earnings per share (EPS) for the quarter. When did Know Labs' stock split? Know Labs shares reverse split before market open on Tuesday, February 18th 2025. The 1-40 reverse split was announced on Tuesday, February 18th 2025. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, February 19th 2025. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split. How do I buy shares of Know Labs? Shares of KNWN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Know Labs own? Based on aggregate information from My MarketBeat watchlists, some other companies that Know Labs investors own include Denali Therapeutics (DNLI), Co-Diagnostics (CODX), Home Depot (HD), Onconova Therapeutics (ONTX), Tonix Pharmaceuticals (TNXP), VBI Vaccines (VBIV) and iBio (IBIO). Company Calendar Last Earnings2/14/2025Today3/12/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorBusiness Services Industry Measuring & controlling devices, not elsewhere classified Sub-IndustryMeasuring And Control Equipment Current SymbolOTCMKTS:KNWN CIK1074828 Webwww.knowlabs.co Phone(206) 903-1351Fax206-826-0451Employees20Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.20) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,580,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-470.76% Debt Debt-to-Equity RatioN/A Current Ratio0.60 Quick Ratio0.60 Sales & Book Value Annual Sales$4.36 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value($0.02) per share Price / BookN/AMiscellaneous Outstanding Shares111,166,000Free Float94,046,000Market Cap$9.00 million OptionableNot Optionable Beta1.50 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?Get This Free Report This page (OTCMKTS:KNWN) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersNow that Trump’s be inaugurated, this day will be key (mark your calendar)Mark your calendar for March 13th. Because on that day, I believe we could see a $2 Trillion shock INTO the...Timothy Sykes | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredWarning: What they're not telling you about these recent selloffsIn light of massive recent selloffs... our senior analyst Dan Ferris has issued a new warning for the American...Stansberry Research | SponsoredSilent Raid on IRAs and 401(k)s Begins—Are You Next?Look around—everything feels oddly steady. Gas prices aren't skyrocketing. Banks aren't collapsing. The mar...Genesis Gold Group | SponsoredTrump announces revenge on BidenA former CIA insider just made a stunning prediction: Trump’s revenge on Biden will end America’s energy cr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Know Labs, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Know Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.